Endothelial nitric oxide synthase is strongly expressed in malignant mesothelioma but does not associate with vascular density or the expression of VEGF, FLK1 OR FLT1

Histopathology

Volumn 39, Issue 2, 2001, Pages 179-186

  Soini, Y ^a   Puhakka, A ^a   Kahlos, K ^a   Saily M ^a   Paakko P ^a   Koistinen, P ^a   Kinnula, V ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Angiogenesis; Mesothelioma; Nitric oxide synthase

Indexed keywords

ANTIBODY; BLOOD CLOTTING FACTOR 8; MESSENGER RNA; NITRIC OXIDE SYNTHASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; CANCER CLASSIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; EPITHELIOID CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MESOTHELIOMA; MESOTHELIUM CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VASCULARIZATION;

ADULT; AGED; BLOOD VESSELS; ENDOTHELIAL GROWTH FACTORS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; MALE; MESOTHELIOMA; MIDDLE AGED; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; PROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035572172     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2001.01211.x     Document Type: Article

References (34)

1. Histological typing of lung and pleural tumours
2. Malignant pleural mesothelioma: Some aspects of epidemiology, differential diagnosis, and prognosis: Histological and immunohistochemical evaluation and follow-up of mesotheliomas diagnosed from 1964 to January 1985
3. Mechanisms of carcinogenesis and clinical features of asbestos-associated cancers
4. Angiogenesis as a predictor of clinical outcome in cancer patients
5. Angiogenesis
6. Production of vascular endothelial growth factor by human tumors inhibits the maturation of dendritic cells
7. Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption
8. Expression of vascular endothelial growth factor promotes colonization, vascularization and growth of transplanted hepatic tissues in the mouse
9. Vascular endothelial growth factor: Possible role in fetal development and placental function
10. A novel regulatory function of proteolytically cleaved VEGF-2 for vascular endothelial and smooth muscle cells
11. Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth
12. Vascular endothelial growth factor (VEGF) and its receptors
13. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
14. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
15. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small lung carcinomas (NSCLCs): Correlation with angiogenesis and survival
16. Regulation of biosynthesis of nitric oxide
17. Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis
18. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR)
19. A novel function of VEGF receptor-2 (KDR): Rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells
20. Expression of inducible nitric oxide synthase in healthy human pleura and in malignant mesothelioma
21. Angiogenic cytokines in mesothelioma: A study of VEGF, FGF-1 and -2, and TGF beta expression
22. Co-expression of vascular endothelial growth factor and its receptor flt-1 in malignant pleural mesothelioma
23. Asbestos-related malignant mesothelioma: Growth, cytology, tumorigenicity and consistent chromosome findings in cell lines from five patients
24. Molecular cloning and characterization of human endothelial nitric oxide synthase
25. Role of nitric oxide in tumor progression: Lesions from experimental tumors
26. Role of nitric oxide in tumour progression: Lesions from human tumours
27. Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53
28. Significant correlation of nitric oxide synthase activity and p53 gene mutation in stage I lung adenocarcinoma
29. Nitric oxide synthase activity in human lung cancer
30. Human mesothelioma samples overexpress both cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (NOS2): In vitro antiproliferative effects of a COX-2 inhibitor
31. Roles of nitric oxide in tumour growth
32. Nitric-oxide production by murine mammary adenocarcinoma cells promotes tumor-cell invasiveness
33. Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis
34. Proliferation, apoptosis and manganese superoxide dismutase in malignant mesothelioma